Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
BMC Musculoskeletal Disorders|January 21, 2017
Plasma miRNA expression profiles in rheumatoid arthritis associated interstitial lung diseaseShomi Oka, Hiroshi Furukawa, Kota Shimada, et al.
Modern Rheumatology|September 16, 2022
Pharmacokinetics of hydroxychloroquine in Japanese systemic lupus erythematosus patients with renal impairmentMikiko Shimizu, Sumito Furudate, Yoshiki Nagai, et al.
Biomarker Insights|September 7, 2019
Serum Metabolomic Profiles of Rheumatoid Arthritis Patients With Acute-Onset Diffuse Interstitial Lung DiseaseHiroshi Furukawa, Shomi Oka, Kota Shimada, et al.
Modern Rheumatology|August 27, 2014
Validation of RAPID3 using a Japanese version of Multidimensional Health Assessment Questionnaire with Japanese rheumatoid arthritis patients: characteristics of RAPID3 compared to DAS28 and CDAINaoto Yokogawa, Tetsuji Kaneko, Yoshiki Nagai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 5, 2022
Efficacy of sulfasalazine for the prevention of Pneumocystis pneumonia in patients with rheumatoid arthritis: A multicentric self-controlled case series studyTakahiro Nunokawa, Naofumi Chinen, Kota Shimada, et al.
Modern Rheumatology|July 10, 2015
MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in JapanShoichi Fukui, Takahiro Nunokawa, Satomi Kobayashi, et al.
The Journal of Rheumatology|August 23, 2006
Diagnostic utility of anti-cyclic citrullinated peptide antibodies for very early rheumatoid arthritisToshihiro Matsui, Kota Shimada, Naoko Ozawa, et al.
Genes|July 29, 2023
Associations of HLA Polymorphisms with Chronic Kidney Disease in Japanese Rheumatoid Arthritis PatientsTakashi Higuchi, Shomi Oka, Hiroshi Furukawa, et al.
BMC Musculoskeletal Disorders|January 20, 2019
Influence of seasonal changes on disease activity and distribution of affected joints in rheumatoid arthritisHiroaki Mori, Tetsuji Sawada, Susumu Nishiyama, et al.
Modern Rheumatology|July 7, 2017
Biomarker for nontuberculous mycobacterial pulmonary disease in patients with rheumatoid arthritis: Anti-glycopeptidolipid core antigen immunoglobulin A antibodiesKanako Iwata, Shomi Oka, Hirotaka Tsuno, et al.
Pageof 9